RT Journal Article
SR Electronic
T1 Midlife “Deaths of Despair” Trends in the US, Canada, and UK, 2001-2019: Is the US an Anomaly?
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2022.10.10.22280916
DO 10.1101/2022.10.10.22280916
A1 Dowd, Jennifer Beam
A1 Angus, Colin
A1 Zajacova, Anna
A1 Tilstra, Andrea M.
YR 2022
UL http://medrxiv.org/content/early/2022/10/10/2022.10.10.22280916.abstract
AB Background Over the past decade, “deaths of despair” were strongly implicated in rising mid-life mortality in the US. Whether despair deaths and mid-life mortality trends are also changing in the peer countries such as the UK and Canada is not well known.Methods We compared all-cause and “despair” mortality trends at mid-life in the US, the UK (constituent nations England & Wales, Northern Ireland, and Scotland) and Canada from 2000-2019, using publicly available mortality data, stratified by three age groups (35-44, 45-54 and 55-64) and by sex. We examined trends in all-cause mortality and mortality by causes categorized as 1) suicides 2) alcohol-specific deaths 3) drug-related deaths. We employ several descriptive approaches to visually inspect age, period, and cohort trends in these causes of death.Results The US and Scotland both saw large increases and high absolute levels of drug-related deaths. The rest of the UK and Canada saw relative increases but much lower absolute levels in by comparison. Alcohol-specific deaths showed less consistent trends that did not track other “despair” causes, with older groups in Scotland seeing steep declines over time. Suicide deaths trended slowly upward in most countries.Conclusions In the UK, Scotland has suffered increases in drug-related mortality comparable to the US, while Canada and other UK constituent nations did not see dramatic increases. Alcohol-specific and suicide mortality generally follow different patterns to drug-related deaths across countries and over time, questioning the utility of a cohesive “deaths of despair” narrative.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThe study received funding from the European Research Council grant ERC-2021-CoG-101002587 (MORTAL)(JBD and AMT). JBD and AMT also acknowledge support from the Leverhulme Trust (Large Centre Grant). Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data and analysis code are available on-line at: https://github.com/VictimOfMaths/DeathsOfDespair/tree/master/Paper https://github.com/VictimOfMaths/DeathsOfDespair/tree/master/Paper